Protecting the ocular surface and improving the quality of life of dry eye patients: a study of the efficacy of an HP-guar containing ocular lubricant in a population of dry eye patients.

PURPOSE The aim of this study was to evaluate the efficacy of a non-Newtonian tear substitute containing 0.4% polyethylene glycol 400 (PEG 400) and 0.3% propylene glycol in an 0.18% hydroxypropyl-guar (HPG) containing vehicle (Systane Lubricant Eye Drops; Alcon) in reducing the signs and symptoms of dry eye, as well as its effect on ocular protection. METHODS Twenty patients with moderate to severe dry eye were enrolled in a 28-day prospective, randomized, controlled study. Subjects self-administered the HPG containing ocular lubricant four times daily (QID) over the study duration. After 28 days, the effect of the HPG containing ocular lubricant was evaluated by means of the Global Staining Score (a measure of the corneal and conjunctival staining), inter-blink tear film stability, Ocular Protection Index (OPI), and subjective symptoms. RESULTS The HPG containing ocular lubricant produced statistically significant improvements compared with baseline in dry eye symptoms (P < 0.0001 at Days 7, 14, and 28); in ocular surface staining, as measured by a reduction in the Global Staining Score (P < 0.0001 at Days 7, 14, and 28); and in the OPI (P = 0.0025 at Day 14 and P = 0.0067 at Day 28). CONCLUSIONS The improvements in ocular surface staining and dry eye symptoms with the HPG containing ocular lubricant -- evident as early as the first follow-up visit (Day 7) and continued throughout the 28 days of the study with a concurrent, increase in OPI to a level greater than unity -- indicate that this preparation is a fast-acting, long-lasting, and effective treatment for dry eye. In concurrence with the results from previously published clinical studies, the HPG containing ocular lubricant has shown efficacy in alleviating the signs and symptoms of dry eye as well as affording improved ocular surface protection.

[1]  George W. Ousler,et al.  The Ocular Protection Index , 2008, Cornea.

[2]  H. Taylor,et al.  The epidemiology of dry eye in Melbourne, Australia , 1998 .

[3]  Christophe Baudouin,et al.  The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). , 2007, The ocular surface.

[4]  R. Bone,et al.  Primary Sjogren syndrome: clinical and immunopathologic features. , 1984, Seminars in arthritis and rheumatism.

[5]  George W Ousler,et al.  An Evaluation of Tear Film Breakup Time Extension and Ocular Protection Index Scores Among Three Marketed Lubricant Eye Drops , 2007, Cornea.

[6]  K. Tsubota,et al.  Dry eyes and video display terminals. , 1993, The New England journal of medicine.

[7]  J. Ubels,et al.  Pre-clinical investigation of the efficacy of an artificial tear solution containing hydroxypropyl-guar as a gelling agent , 2004, Current eye research.

[8]  D Fonn,et al.  A Patient Questionnaire Approach to Estimating the Prevalence of Dry Eye Symptoms in Patients Presenting to Optometric Practices across Canada , 1997, Optometry and vision science : official publication of the American Academy of Optometry.

[9]  B. Munoz,et al.  Prevalence of dry eye among the elderly. , 1997, American journal of ophthalmology.

[10]  M A Lemp,et al.  Tear physiology and dry eyes. , 1977, Survey of ophthalmology.

[11]  T. Edrington,et al.  The Agreement Between Self-Assessment and Clinician Assessment of Dry Eye Severity , 2005 .

[12]  J. McCulley,et al.  Effectiveness of BION tears, Cellufresh, Aquasite, and Refresh Plus for moderate to severe dry eye. , 1998, Advances in experimental medicine and biology.

[13]  R. Baier,et al.  Differential tissue-on-tissue lubrication by ophthalmic formulations. , 2007, Journal of biomedical materials research. Part B, Applied biomaterials.

[14]  B. Evans,et al.  A clinical evaluation of Systane. , 2006, Contact lens & anterior eye : the journal of the British Contact Lens Association.

[15]  Jason J Nichols,et al.  The Lack of Association Between Signs and Symptoms in Patients With Dry Eye Disease , 2004, Cornea.

[16]  Y. Cheng,et al.  Characterization and intermolecular interactions of hydroxypropyl guar solutions. , 2002, Biomacromolecules.

[17]  George W. Ousler,et al.  Factors that Influence the Inter-Blink Interval (IBI) as Measured by the Ocular Protection Index (OPI) , 2002 .

[18]  J. P. Gilbard.  Dry eye, blepharitis and chronic eye irritation: divide and conquer. , 1999, Journal of ophthalmic nursing & technology.

[19]  T. Edrington,et al.  The agreement between self-assessment and clinician assessment of dry eye severity. , 2005, Cornea.

[20]  G. Foulks,et al.  The correlation between the tear film lipid layer and dry eye disease. , 2007, Survey of ophthalmology.

[21]  J. Rinehart,et al.  Clinical evaluation of an HP-guar gellable lubricant eye drop for the relief of dryness of the eye , 2004, Current eye research.

[22]  S. Khwarg,et al.  An open-label evaluation of HP‐Guar gellable lubricant eye drops for the improvement of dry eye signs and symptoms in a moderate dry eye adult population , 2005, Current medical research and opinion.

[23]  D. Meadows,et al.  Novel Gel-Forming Ophthalmic Polymer System for Artificial Tear Solution , 2003 .

[24]  M. Yamada,et al.  Fluorophotometric measurement of pH of human tears in vivo. , 1997, Current eye research.

[25]  J. Buring,et al.  Prevalence of dry eye syndrome among US women. , 2003, American journal of ophthalmology.

[26]  K. Nakamori,et al.  Blinking is controlled primarily by ocular surface conditions. , 1997, American journal of ophthalmology.